About us

In 2020, Quirem Medical B.V. was acquired by Terumo Corporation. This has turned Quirem Medical into a wholly owned subsidiary of Terumo. As a result of the acquisition, Quirem Medical B.V. became part of the Terumo Therapeutic Interventional Oncology (TIO), with the mission to be the partner of choice to improve quality of life and survival of patients living with cancer by offering the best-in-class solutions in Therapeutic Interventional Oncology.

Who we are

Therapeutic Interventional Oncology (TIO) offers fully integrated solutions for treating liver cancer through radioembolization, chemoembolization and ablation.

Where we want to go

Interventional Oncology is a high-growth market in which Terumo aims to become a leader by expanding its therapeutics portfolio beyond treating liver cancer.

How we get there

Terumo builds upon the entrepreneurial DNA of Quirem Medical B.V. focusing on accelerated development and expertise by a high-performance team in collaboration with clinical partners.

Necessary cookies help make a website more usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Enable

Statistical cookies help us understand how visitors use the website by collecting and reporting data anonymously. These cookies therefore do not collect any personal data from visitors.

Cookies are small text files that can be used by websites to make user experiences more efficient. By law, we may store cookies on your device if they are strictly necessary for the use of the website. These are the functional cookies. We need your consent for all other types of cookies. These cookies are named as: preferences and statistics and you do not have to accept them. This website uses different types of cookies. Some cookies are placed by third party services that are displayed on our pages.

This website uses cookies to improve your experience. You can manage your options here.